Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Heme Oxygenase 1 ELISA Kit (AC2701)
Cat.#: ASET-1290
Specifications
Description Human Heme Oxygenase 1 ELISA Kit allows for the in vitro quantitative determination of human Heme Oxygenase 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1954 Rat Progesterone Receptor ELISA Kit (AC3365) Quantitative inquiry ASET-1424 Human Semaphorin 3F ELISA Kit (AC2835) Quantitative inquiry ASET-2384 Mouse LECT2 ELISA Kit (AC3795) Quantitative inquiry ASET-1500 Mouse GHRHR ELISA Kit (AC2911) Quantitative inquiry ASET-1546 Human MAP1B ELISA Kit (AC2957) Quantitative inquiry ASET-1752 Human Otx2 ELISA Kit (AC3163) Quantitative inquiry ASET-1087 Rat Dystrophin ELISA Kit (AC2498) Quantitative inquiry ASET-2155 Rat MAdCAM1 ELISA Kit (AC3566) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-2483 Human Iba1 ELISA Kit (AC3894) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket